7-imidazo[1,2-a]pyridin-6-yl-N-[(4-methoxyphenyl)methyl]isoquinolin-1-amine;2,2,2-trifluoroacetic acid
C26H21F3N4O3 — CID 44525678
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-imidazo[1,2-a]pyridin-6-yl-N-[(4-methoxyphenyl)methyl]isoquinolin-1-amine;2,2,2-trifluoroacetic acid
7-imidazo[1,2-a]pyridin-6-yl-N-[(4-methoxyphenyl)methyl]isoquinolin-1-amine;2,2,2-trifluoroacetic acid (PubChem CID 44525678) has the molecular formula C26H21F3N4O3 and a molecular weight of 494.47 g/mol. Its IUPAC name is 7-imidazo[1,2-a]pyridin-6-yl-N-[(4-methoxyphenyl)methyl]isoquinolin-1-amine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 7-imidazo[1,2-a]pyridin-6-yl-N-[(4-methoxyphenyl)methyl]isoquinolin-1-amine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 44525678 |
| Molecular Formula | C26H21F3N4O3 |
| Molecular Weight | 494.47 g/mol |
| Exact Mass | 494.16 |
| IUPAC Name | 7-imidazo[1,2-a]pyridin-6-yl-N-[(4-methoxyphenyl)methyl]isoquinolin-1-amine;2,2,2-trifluoroacetic acid |
| SMILES | COc1ccc(CNc2nccc3ccc(-c4ccc5nccn5c4)cc23)cc1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C24H20N4O.C2HF3O2/c1-29-21-7-2-17(3-8-21)15-27-24-22-14-19(5-4-18(22)10-11-26-24)20-6-9-23-25-12-13-28(23)16-20;3-2(4,5)1(6)7/h2-14,16H,15H2,1H3,(H,26,27);(H,6,7) |
| InChIKey | HFQXEIOSKDHFJU-UHFFFAOYSA-N |
| XLogP | 5.80 |
| TPSA | 88.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 494.47 |
| LogP ≤ 5 | 5.80 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 44525678 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.